Sharps Technology Partners with The Tie to Strengthen Solana's Institutional Infrastructure
Sharps Technology and The Tie announced a strategic collaboration to strengthen Solana's institutional infrastructure and expand institutional access to the ecosystem. Under the collaboration, STSS will delegate a portion of its SOL treasury holdings, currently more than 2 million SOL, to Stakin by The Tie, which operates non-custodial validator infrastructure across 40+ proof-of-stake networks. "This collaboration with The Tie reflects STSS's commitment to expanding institutional participation in the Solana ecosystem through credible infrastructure and trusted institutional networks," said Alice Zhang, Chief Investment Officer of STSS. "The Tie has built one of the most respected platforms in institutional crypto. By delegating to Stakin by The Tie and engaging directly with their institutional community, we can elevate Solana's visibility among the institutions that matter most, while maintaining full custody and control of our assets."
Trade with 70% Backtested Accuracy
Analyst Views on STSS
About STSS
About the author
Sharps Technology Reports FY Results
- Financial Overview: Sharps Technology reported a FY GAAP EPS of -$10.68, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Figures: The company reported revenue of $7.0 million, and despite the revised figure, it reflects the company's struggles in a competitive market, potentially leading to difficulties in future financing.
- Financial Correction: The release emphasizes the company's efforts to ensure data accuracy, although the negative earnings may attract regulatory scrutiny, impacting its operational credibility.
- Market Reaction Expectations: Given the reported losses, the market is likely to respond negatively to Sharps Technology's stock, potentially leading to further declines in share price.
Sharps Technology Reports FY Financial Results
- Financial Overview: Sharps Technology's FY GAAP EPS stands at -$10.68, indicating significant financial challenges that may lead to a decline in investor confidence.
- Revenue Performance: The reported revenue of $0.2 million falls short of market expectations, highlighting the company's competitive disadvantages that could impact future financing capabilities and operational strategies.
- Financial Health: The ongoing losses and low revenue levels may compel Sharps Technology to reassess its business model and cost structure to achieve sustainable growth and attract investor interest.
- Market Reaction Outlook: Given the poor financial performance, the market is expected to react negatively to Sharps Technology's stock price, prompting investors to closely monitor subsequent strategic adjustments and management responses.
Sharps Technology Reports Strong Financial Results for 2025
- Significant SOL Holdings: As of December 31, 2025, Sharps Technology held over 2 million SOL, with approximately 95% actively staked at a gross annualized yield of around 7%, providing a stable income stream that enhances the company's financial stability.
- Asset Growth: The company reported total assets of $269.1 million, a substantial increase from $7.3 million at the end of 2024, demonstrating the success of its digital asset strategy and boosting stockholders' equity to $264.4 million, indicating a significant improvement in financial health.
- Revenue Structure Optimization: For FY 2025, the company generated total revenue of approximately $7.0 million, including $6.8 million in net staking revenue, reflecting successful positioning in the digital asset space while also achieving revenue from medical device distribution, showcasing a diversified income stream.
- Expanded Strategic Partnerships: Sharps launched its branded validator through Coinbase's institutional infrastructure and established collaborations with multiple strategic partners, including Crypto.com and BitGo, which not only enhance the company's market position but also lay a solid foundation for future growth.
SHARPS TECHNOLOGY AND THE TIE FORM STRATEGIC PARTNERSHIP TO BOOST INSTITUTIONAL ENGAGEMENT IN THE SOLANA ECOSYSTEM
Strategic Collaboration: SHARPS Technology and The Tie have announced a strategic collaboration aimed at enhancing institutional participation in the Solana ecosystem.
Focus on Advancement: The partnership is designed to advance the integration of technology and institutional engagement within the Solana blockchain network.
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.
Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.
MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.
DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.
Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase
Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.
Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.
Sharps Technology Reports FY Results
- Financial Overview: Sharps Technology reported a FY GAAP EPS of -$10.68, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Figures: The company reported revenue of $7.0 million, and despite the revised figure, it reflects the company's struggles in a competitive market, potentially leading to difficulties in future financing.
- Financial Correction: The release emphasizes the company's efforts to ensure data accuracy, although the negative earnings may attract regulatory scrutiny, impacting its operational credibility.
- Market Reaction Expectations: Given the reported losses, the market is likely to respond negatively to Sharps Technology's stock, potentially leading to further declines in share price.
Sharps Technology Reports FY Financial Results
- Financial Overview: Sharps Technology's FY GAAP EPS stands at -$10.68, indicating significant financial challenges that may lead to a decline in investor confidence.
- Revenue Performance: The reported revenue of $0.2 million falls short of market expectations, highlighting the company's competitive disadvantages that could impact future financing capabilities and operational strategies.
- Financial Health: The ongoing losses and low revenue levels may compel Sharps Technology to reassess its business model and cost structure to achieve sustainable growth and attract investor interest.
- Market Reaction Outlook: Given the poor financial performance, the market is expected to react negatively to Sharps Technology's stock price, prompting investors to closely monitor subsequent strategic adjustments and management responses.
Sharps Technology Reports Strong Financial Results for 2025
- Significant SOL Holdings: As of December 31, 2025, Sharps Technology held over 2 million SOL, with approximately 95% actively staked at a gross annualized yield of around 7%, providing a stable income stream that enhances the company's financial stability.
- Asset Growth: The company reported total assets of $269.1 million, a substantial increase from $7.3 million at the end of 2024, demonstrating the success of its digital asset strategy and boosting stockholders' equity to $264.4 million, indicating a significant improvement in financial health.
- Revenue Structure Optimization: For FY 2025, the company generated total revenue of approximately $7.0 million, including $6.8 million in net staking revenue, reflecting successful positioning in the digital asset space while also achieving revenue from medical device distribution, showcasing a diversified income stream.
- Expanded Strategic Partnerships: Sharps launched its branded validator through Coinbase's institutional infrastructure and established collaborations with multiple strategic partners, including Crypto.com and BitGo, which not only enhance the company's market position but also lay a solid foundation for future growth.
SHARPS TECHNOLOGY AND THE TIE FORM STRATEGIC PARTNERSHIP TO BOOST INSTITUTIONAL ENGAGEMENT IN THE SOLANA ECOSYSTEM
Strategic Collaboration: SHARPS Technology and The Tie have announced a strategic collaboration aimed at enhancing institutional participation in the Solana ecosystem.
Focus on Advancement: The partnership is designed to advance the integration of technology and institutional engagement within the Solana blockchain network.
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Biotech Stocks Performance: Several small-cap biotech and healthcare companies saw notable gains in after-hours trading, driven by recent corporate updates and clinical milestones.
Inspira Technologies Update: Inspira Technologies Oxy B.H.N. Ltd. rose 5.88% following a recent agreement for a registered direct offering and a Standby Equity Purchase Agreement, despite no new news on the day.
MediciNova's Clinical Trial Success: MediciNova, Inc. advanced 4.83% after successfully completing patient enrollment in its Phase 2 OXTOX study, which evaluates MN-166 for preventing chemotherapy-induced peripheral neuropathy.
DiaMedica's FDA Meeting: DiaMedica Therapeutics Inc. gained 2.89% after a productive pre-IND meeting with the FDA regarding its study of DM199 in preeclampsia, with an additional non-clinical study requested.
Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase
Collaboration with Coinbase: Sharps Technology is expanding its Solana digital asset treasury strategy through a strategic partnership with Coinbase Global, utilizing Coinbase Prime's custody and OTC desk services.
Acquisition of SOL: The company has acquired over 2 million SOL, valued at over $400 million, with the cryptocurrency currently trading above $210.
